226 related articles for article (PubMed ID: 28689587)
1. Metabolic Manifestations of Hepatitis C Virus: Diabetes Mellitus, Dyslipidemia.
Serfaty L
Clin Liver Dis; 2017 Aug; 21(3):475-486. PubMed ID: 28689587
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus, diabetes and steatosis: clinical evidence in favor of a linkage and role of genotypes.
Mihm S
Dig Dis; 2010; 28(1):280-4. PubMed ID: 20460924
[TBL] [Abstract][Full Text] [Related]
3. Hepatic steatosis and hepatitis C: Still unhappy bedfellows?
Hwang SJ; Lee SD
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():96-101. PubMed ID: 21199519
[TBL] [Abstract][Full Text] [Related]
4. Metabolic alterations and hepatitis C: From bench to bedside.
Chang ML
World J Gastroenterol; 2016 Jan; 22(4):1461-76. PubMed ID: 26819514
[TBL] [Abstract][Full Text] [Related]
5. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection.
Petta S; Cammà C; Di Marco V; Alessi N; Cabibi D; Caldarella R; Licata A; Massenti F; Tarantino G; Marchesini G; Craxì A
Am J Gastroenterol; 2008 May; 103(5):1136-44. PubMed ID: 18477344
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus diversity and hepatic steatosis.
Roingeard P
J Viral Hepat; 2013 Feb; 20(2):77-84. PubMed ID: 23301542
[TBL] [Abstract][Full Text] [Related]
7. Steatosis and insulin resistance in response to treatment of chronic hepatitis C.
Negro F
J Viral Hepat; 2012 Jan; 19 Suppl 1():42-7. PubMed ID: 22233413
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data.
Serfaty L; Capeau J
Liver Int; 2009 Mar; 29 Suppl 2():13-25. PubMed ID: 19187069
[TBL] [Abstract][Full Text] [Related]
9. Impact of hepatitis C virus therapy on metabolism and public health.
Shiffman ML; Gunn NT
Liver Int; 2017 Jan; 37 Suppl 1():13-18. PubMed ID: 28052632
[TBL] [Abstract][Full Text] [Related]
10. Hepatic steatosis in patients coinfected with human immunodeficiency virus/hepatitis C virus: a meta-analysis of the risk factors.
Machado MV; Oliveira AG; Cortez-Pinto H
Hepatology; 2010 Jul; 52(1):71-8. PubMed ID: 20578130
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiology of insulin resistance and steatosis in patients with chronic viral hepatitis.
Basaranoglu M; Basaranoglu G
World J Gastroenterol; 2011 Sep; 17(36):4055-62. PubMed ID: 22039318
[TBL] [Abstract][Full Text] [Related]
12. Liver steatosis and dyslipidemia after HCV eradication by direct acting antiviral agents are synergistic risks of atherosclerosis.
Kawagishi N; Suda G; Nakamura A; Kimura M; Maehara O; Suzuki K; Nakamura A; Ohara M; Izumi T; Umemura M; Nakai M; Sho T; Natsuizaka M; Morikawa K; Ogawa K; Kudo Y; Nishida M; Miyoshi H; Sakamoto N
PLoS One; 2018; 13(12):e0209615. PubMed ID: 30576386
[TBL] [Abstract][Full Text] [Related]
13. Metabolic aspects of hepatitis C viral infection: steatohepatitis resembling but distinct from NASH.
Koike K; Moriya K
J Gastroenterol; 2005 Apr; 40(4):329-36. PubMed ID: 15868369
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus and glucose and lipid metabolism.
Alaei M; Negro F
Diabetes Metab; 2008 Dec; 34(6 Pt 2):692-700. PubMed ID: 19195632
[TBL] [Abstract][Full Text] [Related]
15. Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3.
Abenavoli L; Masarone M; Peta V; Milic N; Kobyliak N; Rouabhia S; Persico M
World J Gastroenterol; 2014 Nov; 20(41):15233-40. PubMed ID: 25386071
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: comparison with hepatitis B virus-infected and hepatitis C virus-cleared patients.
Imazeki F; Yokosuka O; Fukai K; Kanda T; Kojima H; Saisho H
Liver Int; 2008 Mar; 28(3):355-62. PubMed ID: 18290778
[TBL] [Abstract][Full Text] [Related]
17. Steatosis in chronic hepatitis C: relationship to the virus and host risk factors.
Matos CA; Perez RM; Pacheco MS; Figueiredo-Mendes CG; Lopes-Neto E; Oliveira EB; Lanzoni VP; Silva AE; Ferraz ML
J Gastroenterol Hepatol; 2006 Aug; 21(8):1236-9. PubMed ID: 16872303
[TBL] [Abstract][Full Text] [Related]
18. The ratio of insulin-like growth factor-I/insulin-like growth factor-binding protein-3 in sera of patients with hepatitis C virus-related chronic liver disease as a predictive marker of insulin resistance.
Himoto T; Tani J; Miyoshi H; Yoneyama H; Mori H; Inukai M; Masugata H; Goda F; Senda S; Haba R; Masaki T
Nutr Res; 2013 Jan; 33(1):27-33. PubMed ID: 23351407
[TBL] [Abstract][Full Text] [Related]
19. Role of insulin resistance and hepatic steatosis in the progression of fibrosis and response to treatment in hepatitis C.
Sanyal AJ
Liver Int; 2011 Jan; 31 Suppl 1():23-8. PubMed ID: 21205134
[TBL] [Abstract][Full Text] [Related]
20. Steatosis, insulin resistance and fibrosis progression in chronic hepatitis C.
Castera L
Minerva Gastroenterol Dietol; 2006 Jun; 52(2):125-34. PubMed ID: 16557184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
